Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,421,161
+$11,024,469 QoQ
Shares Held
2,277,276
+246.0% QoQ
Ownership
2.71%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. REPL ranks #111 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in REPL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,421,161 | 2,277,276 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,396,692 | 658,096 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $4,754,606 | 1,134,751 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,380,004 | 1,117,331 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,729,128 | 690,167 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $6,915,075 | 571,022 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $6,789,851 | 619,512 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,994,693 | 666,077 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,193,987 | 513,340 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $18,873,783 | 2,238,883 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $9,570,136 | 559,330 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $14,228,588 | 612,773 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $11,376,518 | 644,197 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $4,085,113 | 150,188 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $3,194,535 | 184,976 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $3,945,235 | 225,700 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $2,403,976 | 141,577 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,852,301 | 105,251 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $7,141,757 | 240,950 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $8,248,696 | 214,698 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $13,103,861 | 429,494 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $9,367,464 | 245,543 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,320,289 | 57,354 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $853,223 | 34,335 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $296,607 | 29,750 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||